Li F, Sami A, Noristani HN, et al
The medication mimics and amplifies what your body already does, just with greater intensity and duration
Protective mechanism of trimetazidine in myocardial cells in myocardial infarction rats through ERK signaling pathway
Common gastrointestinal adverse effects reported with Wegovy include: Nausea (affecting approximately 44% of patients) Vomiting (approximately 24%) Dyspepsia (indigestion) Abdominal pain Constipation These symptoms typically occur during dose escalation and often improve over time as the body adjusts to the medication
For your health, ability to maintain your weight, and, specifically, when taking a GLP-1 agonist, managing side effects
Low iron is a common reason for temporary deferral, regardless of medication